Healthy People.
Conditions
Interventions
Intervention group: Participants will receive TMS at five different stimulation intensities (100%, 120%, 140%, 160%, and 180% of resting motor threshold, RMT) across five separate sessions.
Sponsors
Kharazmi University
Eligibility
Sex/Gender
Male
Age
20 Years to 28 Years
Inclusion criteria
Inclusion criteria: Availability for All Study Sessions Current non-use of neuroplasticity-affecting medications (e.g., antidepressants, psychotropics) Absence of TMS contraindications (e.g., history of epilepsy or seizure disorders) No recent strength training (within the past 12 months) or presence of neuromuscular disorders
Exclusion criteria
Exclusion criteria: current use of neuroplasticity-affecting medications (e.g., antidepressants) current use of neuroplasticity-affecting medications (e.g., antidepressants) recent strength training (past 12 months) or neuromuscular disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor Evoked Potentials. Timepoint: Motor evoked potentials (MEPs) were recorded using TMS under four randomized conditions: rest, biceps brachii (BB) activation, triceps brachii (TB) activation, and simultaneous BB-TB co-contraction. Method of measurement: Magstim Rapid 2 stimulator (Magstim Co., UK).;Pre-stimulus EMG. Timepoint: Pre-stimulus EMG were recorded using TMS under four randomized conditions: rest, biceps brachii (BB) activation, triceps brachii (TB) activation, and simultaneous BB-TB co-contraction. Method of measurement: Through the EMGMV6000 device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Rajabi
Kharazmi University
Outcome results
None listed